news Tissue damage and genetic mutations interact to drive pancreatic cancer, finds study 4 February 2021 | By Hannah Balfour (Drug Target Review) New research shows tissue damage to cells carrying KRAS mutations induces epigenetic changes that promote pancreatic cancer.